Ai-min Hui

Pharmacokinetics of Opicapone and Its Metabolites in Healthy White and Chinese Subjects

Changjiang Xu, W. Xue, Kexin Li, 2021, Clinical pharmacology in drug development.

Review of Ribosome Interactions with SARS-CoV-2 and COVID-19 mRNA Vaccine

Jiao Wei, Ai-min Hui, 2022, Life.

BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19

Rui-Ru Ji, U. Şahin, C. Qin, 2021, Vaccines.

A phase I study of FCN-411, a pan-HER inhibitor, in EGFR-mutated advanced NSCLC after progression on EGFR tyrosine kinase inhibitors.

Cheng-ling Zhao, H. Pan, Jiangtao Sun, 2022, Lung cancer.

Safety, Pharmacokinetics, and Preliminary Activity of CDK4/6 Inhibitor FCN-437c in Chinese Female Patients with HR+HER2- Advanced Breast Cancer (ABC) From Phase Ia Study

Chang Xu, Xiaojia Wang, Jian Zhang, 2021 .

Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males

Jiangfan Li, Lei Diao, Kexin Li, 2023, Advances in Therapy.

Avatrombopag for adult chronic primary immune thrombocytopenia: a randomized phase 3 trial in China

Hui Wang, Jing Sun, Zhongxing Jiang, 2023, Research and Practice in Thrombosis and Haemostasis.